JENBURKT PHARMACEUTICALS
Back to Balance Sheet
|
JENBURKT PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹23 Cr | ₹19 Cr | ₹16 Cr | ₹16 Cr | ₹21 Cr |
What is the latest Total Current Liabilities ratio of JENBURKT PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹23 Cr |
| Mar2025 | ₹19 Cr |
| Mar2024 | ₹16 Cr |
| Mar2023 | ₹16 Cr |
| Mar2022 | ₹21 Cr |
How is Total Current Liabilities of JENBURKT PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹23 Cr | 23.00 | |
| Mar2025 | ₹19 Cr | 14.90 | |
| Mar2024 | ₹16 Cr | 3.91 | |
| Mar2023 | ₹16 Cr | -25.93 | |
| Mar2022 | ₹21 Cr | - | |
Compare Total Current Liabilities of peers of JENBURKT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JENBURKT PHARMACEUTICALS | ₹467.2 Cr | -0.1% | -2.5% | -17.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,848.0 Cr | -1.4% | -1.3% | 21.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 2.7% | 16.1% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,109.0 Cr | -1.5% | -3.3% | 35.6% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -0.7% | 1.4% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,328.0 Cr | 3.9% | -1.8% | 0.4% | Stock Analytics | |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JENBURKT PHARMACEUTICALS | -0.1% |
-2.5% |
-17.3% |
| SENSEX | -0.6% |
1.1% |
-3.2% |
You may also like the below Video Courses